{
    "code": "01057915",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057915",
    "time": "2016-01-08 03:13:07",
    "許可證字號": "衛署藥製字第057915號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/04\/26",
    "發證日期": "102\/04\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105791502",
    "中文品名": "利伏抗膜衣錠100毫克",
    "英文品名": "Leevk F.C. Tablets 100mg",
    "適應症": "治療正值急性轉化期(BLAST CRISIS)、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病(CML)患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病(CML)的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ ALL)且併用化療之成年人。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病(Ph+ ALL)之單一療法。治療患有與血小板衍生生長因子受體（PDGER)基因重組相關之骨髓發育不全症候群(MDS)\/骨髓增生性疾病(MPD)之成人患者。治療患有系統性肥大細胞增生症(SM)，限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。治療嗜伊紅性白血球增加症候群(HES)與或慢性嗜伊紅性白血病(CEL)且有血小板衍生生長因子受體(PDGER)基因重組之成人患者。作為成人KIT(CD 117)陽性胃腸道基質瘤完全切除（complete gross resection）後之術後輔助治療。治療患有無法手術切除、復發性或轉移性且有血小板衍生生長因子受體(PDGER)基因重組之隆突性皮膚纖維肉瘤(DFSP)之成人患者。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝 2-1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "IMATINIB MESYLATE",
    "限制項目": [
        "01國產",
        "24監視期滿學名藥",
        "61完成BE試驗"
    ],
    "申請商名稱": "0402601200  中國化學製藥股份有限公司新豐工廠",
    "申請商地址": "新竹縣新豐鄉坑子口182之1號",
    "主製造廠": {
        "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000710",
            "成分名稱": "IMATINIB MESYLATE",
            "含量描述": "(eq. to Imatinib 100mg)",
            "含量": "119.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Leevk FCT 100mg In-104-02-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=003&Type=9"
        },
        {
            "title": "0105791500001-102-12-20.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=002&Type=9"
        },
        {
            "title": "0205791500001-102-07-10.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=001&Type=9"
        },
        {
            "title": "Leevk FCT100 mg Al-foil-104-02-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=005&Type=8"
        },
        {
            "title": "Leevk FCT Box-104-02-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=004&Type=8"
        },
        {
            "title": "Leevk FCT 100 mg La-104-02-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=003&Type=8"
        },
        {
            "title": "0105791500002-102-12-20.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=002&Type=8"
        },
        {
            "title": "0205791500002-102-07-10.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057915&Seq=001&Type=8"
        }
    ]
}